EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

CPAP vs HFNC in treatment of patients with COVID-19 ARDS: A retrospective propensity-matched study

Ivan Šitum, Lovro Hrvoić, Ante Erceg, Anja Mandarić, Dora Karmelić, Gloria Mamić, Nikolina Džaja, Anđela Babić, Slobodan Mihaljević, Mirabel Mažar, Daniel Lovrić

Canadian Journal of Respiratory Therapy · 31.10.2024 · 60

DOI: 10.29390/001c.125145 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Journal of Respiratory Therapy, online erschienen am 31.10.2024. Verfasst von Ivan Šitum und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Reanimatology, Intensive Medicine and Pain Therapy University Hospital Centre Zagreb. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Previous studies exploring the application of noninvasive ventilation or high-flow nasal cannula in patients with COVID-19-related acute respiratory distress syndrome (ARDS) have yielded conflicting results on whether any method of respiratory support is superior. Our aim is to compare the efficacy and safety of respiratory therapy with high-flow nasal cannula and noninvasive ventilation with continuous positive airway pressure in treatment of COVID-19-related ARDS.

Methods

This is a retrospective cohort study based on data from patients who received respiratory support as part of their treatment in the COVID intensive care unit at the University Hospital Centre Zagreb between February 2021 and February 2023. Using propensity score analysis, 42 patients treated with high-flow nasal cannula (HFNC group) were compared to 42 patients treated with noninvasive ventilation with continuous positive airway pressure (CPAP group). Primary outcome was intubation rate.

Results

Intubation rate was 71.4% (30/42) in the HFNC group and 40.5% (17/42) in the CPAP group ( p = 0.004). Hazard ratio for intubation was 3.676 (95% confidence interval [CI] 1.480 to 9.232) with the HFNC versus CPAP group. Marginally significant difference in survival between the two groups was observed at 30 days ( p = 0.050) but was statistically significant at 60 days ( p = 0.043).

Conclusions

Respiratory support with high-flow nasal cannula and noninvasive ventilation with continuous positive airway pressure yielded significantly different intubation rates in favour of continuous positive airway pressure. The same patients also had better 30-day and 60-day survival post-admission.

Schlagwörter

Stichwörter der Autor:innen

acute respiratory distress syndromecovid-19endotracheal intubationmechanical ventilationpneumonia

Autor:innen und Institutionen

  • Department of Anesthesiology, Reanimatology, Intensive Medicine and Pain Therapy University Hospital Centre Zagreb.
  • Department of Emergency Medicine University Hospital Centre Zagreb.
  • Department of Cardiology University Hospital Centre Zagreb.

Zitieren

APA

Šitum, I., Hrvoić, L., Erceg, A., Mandarić, A., Karmelić, D., Mamić, G., Džaja, N., Babić, A., Mihaljević, S., Mažar, M., & Lovrić, D. (2024). CPAP vs HFNC in treatment of patients with COVID-19 ARDS: A retrospective propensity-matched study. Canadian Journal of Respiratory Therapy, 60. https://doi.org/10.29390/001c.125145

Vancouver

Šitum I, Hrvoić L, Erceg A, Mandarić A, Karmelić D, Mamić G, et al. CPAP vs HFNC in treatment of patients with COVID-19 ARDS: A retrospective propensity-matched study. Canadian Journal of Respiratory Therapy. 2024;60. doi:10.29390/001c.125145

BibTeX
@article{itum2024,
  author = {Šitum, Ivan and Hrvoić, Lovro and Erceg, Ante and Mandarić, Anja and Karmelić, Dora and Mamić, Gloria and Džaja, Nikolina and Babić, Anđela and Mihaljević, Slobodan and Mažar, Mirabel and Lovrić, Daniel},
  title = {CPAP vs HFNC in treatment of patients with COVID-19 ARDS: A retrospective propensity-matched study},
  journal = {Canadian Journal of Respiratory Therapy},
  year = {2024},
  volume = {60},
  doi = {10.29390/001c.125145}
}
Kostenlos starten →